Drug
Itolizumab Bmab 600
Itolizumab Bmab 600: highest development phase Phase 1, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itolizumab [Bmab 600] NCT04128579 | Phase 1 | Lupus Erythematosus |
Latest
No recent events.
Follow Itolizumab Bmab 600 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.